TY  - JOUR 
AU  - Gómez Escudero, Jesús
AU  - Maniati, Eleni
AU  - Holdsworth, Julie
AU  - Beattie, Gordon
AU  - Hijazi Vega, Maruan
AU  - Guelbert, Matt
AU  - Elorbany, Samar
AU  - Cutillas, Pedro R.
AU  - Wang, Jun
AU  - Hodivala-Dilke, Kairbaan M.
AU  - D'Amico, Gabriela
PY  - 2026
UR  - http://hdl.handle.net/10366/171999
AB  - [EN]Despite its established role in breast cancer treatment, Doxorubicin treatment remains subject to adaptive resistance
mechanisms that extend beyond cancer cell intrinsic alterations ultimately reducing therapy efficacy. Our study in...
LA  - eng
PB  - Springer
KW  - Angiocrine
KW  - Chemoresistance
KW  - Breast cancer
KW  - NF-κB
KW  - Doxorubicin
TI  - Tumour endothelial cell reprogramming orchestrates angiocrine signalling to drive chemoresistance in breast cancer
DO  - 10.1007/s10456-026-10063-7
T2  - Angiogenesis
VL  - 29
ER  -